ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,683.00
-0.01%
S&P ASX All Technology
3,008.10
0.02%
Brent Oil
87.335
0.13%
US Dollar vs AUD
1.53186
-0.48%
Bitcoin
63,754.05
-0.82%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Novartis AG (NVS)

  7. Novartis AG (NVS) News

NVS Novartis AG

98.35
0.00 (0.00%)
Pre Market
Last Updated: 18:38:26
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Novartis AG NVS NYSE Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 98.35 18:38:26
Open Price Low Price High Price Close Price Previous Close
98.35
more quote information »

Recent News

Date Time Source Heading
23/4/202421:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
16/4/202404:00PRNUSNew Novartis Fabhalta® (iptacopan) data show clinically..
11/4/202421:00GLOBEArvinas Enters into a Transaction with Novartis, including a..
10/4/202421:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
07/4/202406:16PRNUSNew Novartis data show early addition of twice-yearly*..
16/2/202408:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/2/202408:52EDGAR2Form SC TO-C - Written communication relating to an issuer..
06/2/202422:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
06/2/202409:06EDGAR2Form SC TO-C - Written communication relating to an issuer..
03/2/202406:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202423:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202423:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202423:42EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
31/1/202423:38EDGAR2Form 20-F - Annual and transition report of foreign private..
31/1/202422:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
22/1/202417:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
12/1/202422:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
12/1/202405:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
09/1/202405:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
09/1/202402:41DJNNovartis on Track for Record High Close -- Data Talk
08/1/202422:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202418:01DJNNovartis's Scemblix Drug Meets Main Goals in Late-Stage..
06/1/202402:15DJNNovartis to Make Pluvicto Radioligand Therapy at..
02/1/202423:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
11/12/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202318:02DJNNovartis Drug Meets Primary Goal in Late-Stage Study for..
11/12/202311:39PRNUSNovartis presents new 48-week results from Phase III..
06/12/202321:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
06/12/202316:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202322:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202322:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
29/11/202307:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202318:12DJNNovartis Raises Mid-Term Sales Growth Targets
14/11/202301:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202323:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202317:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202318:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202316:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202322:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202321:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202318:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202316:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
07/10/202308:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx
04/10/202321:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202320:17DJNNovartis Spinoff Sandoz Group Valued at $11.2 Billion in..
02/10/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202317:10DJNNovartis Says Kidney Drug Phase 3 Trial Reaches Positive..
26/9/202316:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..

Your Recent History

NYSE
NVS
Novartis
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved